Table 4.

Model predicting 12-month DAS28 remission in the follow-up cohort of 481 early RA patients with moderate–high disease activity at baseline

Variables	OR (95% CI)
DAS28 T0, <5.1=1	1.54 (0.94 to 2.51)
HAQ T0, <1.5=1	1.29 (0.75 to 2.23)
VERA, yes=1	2.03 (1.25 to 3.30)
Anti-CCP+, yes=1	1.39 (0.94 to 2.07)
Erosions T0, yes=1	0.47 (0.29 to 1.08)
DMARD within 3 months from disease onset, yes=1	1.65 (1.06 to 2.55)
Hosmer–Lemeshow test	p=0.59

CCP, cyclic citrullinated protein; DAS28, disease activity score in 28 joints; DMARD, disease-modifying antiheumatic drug; HAQ, health assessment questionnaire; T0, baseline; VERA, very early rheumatoid arthritis.

Bold type indicates that the p value is less than 0.05.